Mohammad Mahdi Nasiri, the CEO of Iran's Health Insurance Organization, announced a significant reduction in the costs paid by special and hard-to-treat patients at his recent press conference. According to Nasiri, over the past two and a half years, in collaboration with the Special and Hard-to-Treat Patients Fund, 30 trillion tomans (thousand billion tomans) have been reduced from the direct costs of patients. This cost reduction demonstrates the serious commitment of the Health Insurance Organization and the Ministry of Health to support these patients.
Collaboration between Health Insurance and the Ministry of Health
The CEO of the Health Insurance Organization emphasized the importance of the family physician program, stating that this initiative is designed to improve patients' access to medical services and reduce their financial burden. Nasiri stressed that this program is currently being implemented in 64 cities across the country, aiming to enhance the level of health and medical services for patients.
Positive consequences of cost reduction
The reduction of medical costs for special and hard-to-treat patients can have positive impacts on the quality of life for these individuals. Many patients face serious financial challenges, and this cost reduction can alleviate their financial burden. Nasiri also pointed out that these actions not only benefit patients but can also contribute to improving the overall health status of the community.
Furthermore, Nasiri referred to the future plans of the Health Insurance Organization and expressed hope that with continued close collaboration with the Ministry of Health, they can provide better services to patients. These actions are a sign of ongoing efforts to enhance the country's health system and address the needs of special and hard-to-treat patients.
Read more: Saving the life of a 2-year-old child in Dehdasht with brain surgery
